Browse medicines
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Medicine type
Approval status
AllApproved in the United States (FDA)Approved in the European Union (EMA)In Phase 3 testingIn Phase 2 testingUsed in a way not covered by an approval, or made by a compounding pharmacyDietary supplement; not FDA-approved as a medicineFDA accelerated approval (based on an earlier result expected to predict benefit; follow-up evidence may be required)Laboratory or animal-stage researchControlled substance; no approved US useWithdrawn from the market
Amount of information
Showing 1–2 of 2 records
5'-Nucleotidase (Cpc Chondrocyte Preparation)
Protein medicineUsed in a way not covered by an approval, or made by a compounding pharmacyExpanded recordUse listed on the medicine record
For topical / local external use; apply only to the target local area according to labeling directions.
Cocarboxylase (Enbrace Hr / Paxlyte)
Protein medicineUsed in a way not covered by an approval, or made by a compounding pharmacyExpanded recordUse listed on the medicine record
INDICATIONS: EnBrace HR ® is indicated in the TREATMENT of vitamin deficiency - specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate. Requirements of vitamin B 9 and/or vitamin B 12 in excess of normal due to pregnancy can usually be met with oral supplementation.